final thoughts on optimizing the treatment of mcrc
Published 10 years ago • 278 plays • Length 5:41Download video MP4
Download video MP3
Similar videos
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
2:55
final thoughts
-
1:06
dr. pant on the future of mcrc treatment
-
3:21
newly diagnosed mcrc treatment goals
-
5:31
practical advice for using regorafenib
-
13:11
treatment sequencing in metastatic colorectal cancer
-
7:08
the regorafenib dose optimization study
-
59:41
what‘s behind the positive effects of neuromodulation on gut function?
-
1:03:29
dr. theodore c. friedman's webinar on optimal replacement for hypopituitarism and sheehan’s
-
13:36
pharmacology - cancer drugs – cell cycle inhibitors (made easy)
-
2:32
precision decision
-
4:58
tas-102 in refractory metastatic colorectal cancer
-
3:11
moving the needle 2023 - panel three - ca cure mayo clinic
-
9:24
frontline-therapy decision factors for mcrc
-
7:46
clinical use of regorafenib in mhcc
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
8:04
first- and second-line treatment for mcrc in specific populations
-
5:19
i-o therapy in mcrc: ipilimumab nivolumab
-
11:17
progress report iii - jázmin németh
-
3:44
disease progression after maintenance therapy for locally advanced or metastatic uc
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
16:43
progress report iv - noémi ágnes galajda